singl
infecti
rout
use
virus
human
viral
infect
transmiss
occur
multipl
path
ingest
contamin
food
drink
sexual
contact
exposur
infect
blood
exchang
saliva
aerosol
gener
sneez
cough
common
exampl
virus
isol
oral
caviti
includ
rotaviru
noroviru
hiv
hepat
c
viru
herp
simplex
virus
viru
influenza
virus
influenza
common
cold
virus
among
frequent
type
human
viral
infect
common
cold
gener
life
threaten
usual
resolv
without
medic
intervent
caus
group
highli
contagi
airborn
virus
vaccin
avail
best
protect
avoid
close
proxim
individu
infect
contrast
influenza
result
mani
fatal
particularli
elderli
individu
suppress
immun
system
annual
modifi
influenza
vaccin
avail
western
world
initi
offer
individu
risk
avail
everyon
howev
note
influenza
vaccin
effect
among
peopl
receiv
influenza
vaccin
prior
year
comparison
vaccin
effect
among
get
influenza
vaccin
previou
year
substanti
lower
occasion
new
influenza
variant
may
caus
pandem
result
zoonosi
ie
transmiss
anim
flu
viru
human
genet
recombin
precis
reassort
gene
segment
human
viru
nonhuman
form
cross
speci
recent
exampl
swine
flu
avian
bird
flu
sometim
confus
zoonot
sever
acut
respiratori
syndrom
viru
corona
viru
worldwid
polici
reduc
elimin
risk
epidem
success
sever
infecti
diseas
larg
erad
control
western
world
result
nation
vaccin
program
success
exampl
erad
smallpox
viru
follow
implement
worldwid
vaccin
strategi
approach
succeed
smallpox
viru
variola
essenti
compris
singl
strain
anim
vector
approach
measl
anoth
exampl
demonstr
success
vaccin
measl
highli
contagi
infect
respiratori
system
spread
aerosol
transmiss
contact
nasal
oral
fluid
effect
vaccin
avail
usa
measl
declar
elimin
world
health
assembl
global
goal
propos
elimin
diseas
target
reduct
mortal
unfortun
recent
measl
outbreak
usa
case
mostli
unvaccin
individu
http
wwwcdcgovmeasl
result
new
vaccin
vaccin
polici
also
improv
medic
care
develop
novel
drug
worldwid
infecti
diseas
fatal
increas
past
two
decad
howev
signific
decreas
worldwid
expect
equival
western
world
resourc
becom
avail
area
global
approach
erad
polio
anoth
exampl
current
world
popul
live
region
collabor
strateg
endgam
plan
place
erad
last
reservoir
polio
global
polio
erad
initi
list
viral
infect
viral
diseas
extens
erad
one
pathogen
may
provid
nich
anoth
pathogen
becom
virul
natur
acquir
immun
exposur
pathogen
like
provid
best
protect
recur
infect
presenc
viabl
viru
oral
fluid
specimen
typic
demonstr
screen
viral
nucleic
acid
initi
viral
nucleic
acid
isol
oral
fluid
sampl
directli
centrifug
perform
concentr
viru
usual
follow
pcr
amplif
viral
nucleic
acid
fragment
use
signal
amplif
technolog
hiv
analysi
frequent
use
commerci
assay
base
viral
nucleic
acid
amplif
amplicor
monitor
test
roch
diagnost
indianapoli
usa
exampl
commerci
assay
base
signal
amplif
rna
assay
siemen
ag
munich
germani
viral
nucleic
method
sensit
consid
less
contagi
pathogen
sampl
inactiv
initi
viral
nucleic
acid
isol
protocol
howev
detect
viral
nucleic
acid
rel
expens
requir
train
personnel
specif
equip
may
alway
proof
activ
infect
ultim
cultiv
confirmatori
test
may
need
obtain
definit
diagnosi
detect
viral
antigen
indirect
fluoresc
antibodi
label
electron
microscop
techniqu
use
detect
presenc
intact
viral
particl
note
presenc
microscop
intact
viral
particl
specif
biolog
fluidmatrix
distinguish
viableinfecti
viru
noninfecti
viru
list
exampl
viabl
virus
detect
oral
fluid
sampl
provid
tabl
contrast
serum
plasma
standard
protocol
salivaor
fluid
collect
thu
saliva
may
refer
stimul
unstimul
saliva
sampl
obtain
oral
swab
brush
filter
centrifug
saliva
use
detect
free
viru
viru
may
free
use
whole
saliva
oral
swab
virus
easili
cultiv
contrast
bacteria
directli
grown
cultur
media
requir
specif
live
cell
support
replic
human
papillomaviru
hepat
c
viru
herp
simplex
viru
human
herpesviru
coronavirus
rhinovirus
exampl
virus
known
difficult
cultur
determin
presenc
viabl
viru
oral
fluid
sampl
alway
indic
viru
transmit
oral
case
cytomegaloviru
member
herpesvirida
famili
known
transmiss
occur
via
direct
contact
bodi
fluid
although
serolog
suggest
preval
cytomegaloviru
blood
donor
routin
test
activ
cytomegaloviru
infect
viru
blood
cell
associ
product
consid
cytomegaloviru
safe
howev
situat
saliva
probabl
differ
cytomegaloviru
transmiss
rout
saliva
similar
follow
infect
viru
herpesvirida
member
respons
caus
infecti
mononucleosi
kiss
diseas
oral
hairi
leukoplakia
contrast
mani
studi
focus
hiv
describ
inactiv
viru
salivari
compon
indic
likelihood
transmit
hiv
saliva
extrem
low
report
mention
isol
viabl
hiv
oral
fluid
sampl
analysi
infect
saliva
sampl
show
lack
specif
immunoglobulin
nonspecif
antivir
activ
addit
report
human
virus
studi
describ
presenc
viabl
plant
pathogen
human
oral
sampl
exampl
tobacco
mosaic
viru
identifi
sputum
sampl
smoker
although
specul
associ
plant
viru
specif
communic
diseas
establish
recent
exampl
demonstr
viral
nucleic
acid
oral
caviti
amplif
specif
viral
nucleic
acid
fragment
shown
tabl
besid
current
wide
util
viral
nucleic
detect
method
diagnost
antigen
also
use
demonstr
activ
infect
exampl
detect
hepat
b
surfac
antigen
common
test
amen
salivari
diagnosi
hepat
b
viru
antigen
assay
demonstr
activ
viral
infect
use
oral
sampl
describ
ebola
rabi
hiv
antigen
eg
hiv
often
present
higher
level
viral
genom
identifi
abund
viral
protein
copi
per
virion
often
util
simpler
techniqu
detect
unboundfre
solubl
protein
rather
viral
nucleic
acid
amplif
seroconvers
effect
test
presenc
viral
antigen
best
achiev
includ
dissoci
step
hiv
infect
test
propos
method
detect
acut
infect
within
seroconvers
window
august
first
rapid
test
detect
antigen
antibodi
approv
us
food
drug
administr
fda
sale
determin
antigenantibodi
combo
test
aler
inc
orlando
fl
usa
use
train
profession
well
suit
outreach
set
access
health
care
limit
howev
antigenantibodi
combo
test
replac
viral
nucleic
acid
confirmatori
test
approv
screen
algorithm
design
valid
test
still
appli
combo
test
even
test
indic
presenc
immunoglobulin
hiv
antigen
use
test
altern
viral
nucleic
viral
load
test
valid
serolog
assay
thought
limit
antigen
test
show
poor
clinic
sensit
viral
load
drop
virionsml
note
good
correl
viral
rna
seen
within
seroconvers
window
nucleic
acid
amplif
compat
simultan
screen
detect
multipl
pathogen
singl
sampl
use
multipl
pair
dna
primer
specif
target
microorgan
develop
fulli
integr
rapid
test
devic
capabl
analyz
clinic
sampl
panel
specif
pathogen
target
would
great
valu
use
devic
feasibl
current
avail
viral
nucleic
technolog
howev
cost
issu
still
need
address
recent
technolog
advanc
allow
analysi
deep
sequenc
human
salivari
microbiom
creat
catalog
microorgan
present
saliva
oral
mucosa
analysi
salivari
virom
viru
subset
salivari
microbiom
demonstr
major
oral
virus
bacteriophag
postul
phage
requir
bacteri
cell
replic
probabl
play
import
role
microbi
divers
health
oral
caviti
may
also
influenc
suscept
human
viral
infect
optim
oral
fluid
viral
nucleic
method
combin
avail
sequenc
analysi
technolog
provid
use
tool
identifi
known
well
unknown
virus
although
wide
util
immunolog
detect
activ
infect
report
infect
hiv
exampl
dengu
iga
serum
saliva
detect
soon
infect
region
moreov
igmigg
level
may
use
distinguish
primari
secondari
infect
howev
antibodi
test
tabl
alway
detect
activ
infect
valid
document
exposur
uncommon
virus
west
nile
viru
antibodi
test
also
use
screen
identifi
individu
expos
human
viru
ii
hepat
virus
b
c
although
antibodi
assay
gener
unequivoc
diagnos
activ
viral
infect
valuabl
tool
track
exposur
pathogen
antibodi
screen
use
epidemiolog
studi
monitor
larg
popul
immun
common
viral
infect
wherea
screen
young
children
presenc
antibodi
infecti
agent
thought
elimin
use
monitor
potenti
pathogen
use
saliva
clinic
sampl
approach
sampl
collect
noninvas
particip
home
mail
nation
test
laboratori
wide
accept
antibodi
detect
blood
also
detect
saliva
howev
fluctuat
differ
concentr
salivari
flow
rate
vari
circadian
rhythm
saliva
composit
variabl
bloodplasma
moreov
antibodi
isotyp
differ
salivari
gland
produc
secret
salivari
iga
wherea
igg
igm
enter
oral
caviti
leakag
bloodstream
gingiv
crevicular
fluid
present
lower
concentr
anoth
issu
studi
util
oral
sampl
method
collect
exampl
respect
antibodi
type
composit
whole
saliva
quit
differ
composit
gingiv
crevicular
fluid
transud
close
resembl
blood
antibodi
detect
consequ
high
abund
seroconvers
collect
method
less
critic
case
target
analyt
nucleic
acid
previou
studi
explor
develop
modular
microfluid
test
devic
multiplex
analysi
saliva
sampl
versatil
gener
antibodi
assay
fig
evalu
use
two
set
saliva
sampl
collect
use
differ
protocol
set
wih
obtain
woman
interag
hiv
studi
compris
sampl
upon
collect
immedi
store
preserv
wherea
set
sampl
collect
studi
fund
nation
institut
dental
craniofaci
research
nih
grant
compris
sampl
upon
collect
clarifi
use
spong
uplink
collector
set
pair
serum
saliva
sampl
test
parallel
valid
saliva
result
figur
show
result
obtain
wih
fig
sampl
fig
assay
result
present
normal
valu
ratio
signal
measur
test
line
divid
signal
measur
flow
control
line
assay
threshold
valu
sampl
design
reactiv
determin
averag
valu
obtain
control
sampl
sampl
uniformli
gener
higher
assay
valu
sampl
appar
independ
protocol
similar
pattern
compar
saliva
level
also
observ
infecti
diseas
noroviru
refer
famili
rna
nonenvelop
virus
major
caus
nonbacteri
gastroenter
transmit
rout
follow
exposur
fomit
food
water
possibl
also
direct
contact
shellfish
grown
contamin
water
among
common
sourc
outbreak
noroviru
infect
viral
receptor
util
blood
type
b
lea
leb
present
saliva
date
definit
evid
viru
directli
transmit
saliva
typic
pathogen
transfer
amongst
individu
close
contact
includ
locat
hospit
cruis
ship
airlin
well
food
handler
viru
surviv
day
water
extrem
small
dose
need
transfer
handsmouth
contamin
surfac
eg
doorknob
bed
sheet
ceram
surfac
transmit
infect
viru
rel
resist
common
disinfect
thu
increas
risk
transmiss
common
human
strain
noroviru
genet
cluster
sever
laboratori
work
develop
compound
block
noroviru
receptor
base
blood
group
carbohydr
structur
bind
viru
contrast
noroviru
rabi
viru
usual
transmit
via
saliva
follow
bite
infect
anim
result
enceph
suggest
spelunk
may
becom
infect
inhal
aerosol
bat
coloni
hang
upsid
cave
diseas
preval
area
endem
dog
rabi
infect
bat
viru
bind
nicotin
receptor
muscl
fiber
newli
infect
anim
migrat
via
nerv
brain
replic
spread
via
neuron
rout
salivari
gland
ultim
appear
saliva
anim
bite
human
spread
central
nervou
system
subsequ
viru
found
saliva
human
host
rabi
antigen
antibodi
detect
saliva
infect
anim
human
typic
late
infect
make
serolog
detect
littl
practic
valu
pcr
detect
rabi
viru
saliva
report
appropri
vaccin
postexposur
prophylaxi
rabi
immun
globulin
vaccin
effect
earli
treatment
along
antivir
drug
otherwis
diseas
typic
fatal
massiv
anim
control
vaccin
made
mortal
usa
rel
rare
fewer
two
death
per
year
human
papillomavirus
famili
dna
virus
infect
epitheli
cell
skin
mucosa
differ
strain
human
papillomaviru
abl
infect
genit
reproduct
tract
oral
caviti
caus
wart
predominantli
hand
feet
usa
human
papillomaviru
infect
lifetim
clear
without
caus
diseas
antibodi
test
screen
potenti
activ
human
papillomaviru
infect
therefor
consid
relev
twelv
strain
human
papillomaviru
consid
high
risk
mean
lead
cancer
primarili
cervic
oral
cancer
human
papillomaviru
strain
two
strain
frequent
associ
cancer
premalign
condit
cervic
cancer
attribut
two
strain
howev
beachler
et
al
studi
individu
found
preval
oral
strain
human
papillomavirus
human
papillomaviru
strain
includ
nation
prevent
program
includ
administr
papillomaviru
vaccin
oral
human
papillomaviru
infect
higher
preval
individu
uninfect
hiv
individu
result
higher
risk
develop
human
cancer
particularli
head
neck
cancer
interest
case
studi
two
coupl
human
tonsillar
carcinoma
human
papillomaviru
strain
ident
partner
suggest
possibl
infecti
natur
oropharyng
cancer
present
oraldna
lab
access
genet
llc
commerci
avail
salivari
diagnost
test
human
papillomaviru
oral
sampl
collect
swab
place
transport
media
sent
central
laboratori
nucleic
human
papillomaviru
detect
strain
identif
salivari
test
orarisk
human
papillomaviru
identifi
sever
human
papillomaviru
type
focu
human
human
type
commonli
link
oral
cancer
viru
member
herpesvirida
famili
dna
virus
known
caus
diseas
human
lymphocryptoviru
target
epitheli
cell
also
refer
human
herpesviru
oral
transmit
viru
one
common
virus
worldwid
infect
rate
adult
popul
although
exposur
viru
high
primari
infect
asymptomat
howev
carriag
associ
malign
includ
nasopharyng
carcinoma
oral
hairi
leukoplakia
may
play
role
mani
benign
malign
diseas
oral
hairi
leukoplakia
often
consequ
opportunist
infect
viru
individu
viru
spread
sexual
contact
blood
transfus
organ
transplant
howev
frequent
transmiss
thought
occur
saliva
viru
surviv
object
surfac
long
stay
moist
thu
easili
transmit
eg
share
drink
vaccin
avail
prevent
infect
viru
caus
major
infecti
mononucleosi
case
also
known
pfeiffer
kiss
diseas
common
among
young
adult
teenag
infect
may
caus
fatigu
malais
may
take
sever
month
recov
clinic
symptom
indic
symptom
infecti
mononucleosi
confirm
presenc
atyp
lymphocyt
serolog
test
past
serolog
diagnost
test
detect
presenc
heterophil
antibodi
weak
antibodi
multispecif
activ
poorli
defin
antigen
epidemiolog
studi
use
detect
specif
antibodi
saliva
determin
popul
immun
report
current
sensit
igg
reflect
past
infect
igm
reflect
current
infect
diagnost
develop
reduc
rate
thu
rule
infecti
mononucleosi
previous
presenc
infecti
viru
saliva
demonstr
abil
saliva
extract
transform
lymphocyt
cultur
nucleic
detect
sensit
standard
method
detect
infect
sever
studi
describ
detect
simplex
viru
antibodi
nucleic
acid
oral
sampl
antibodi
test
specif
type
herp
simplex
viru
like
nucleic
acid
test
distinguish
herp
simplex
viru
herp
simplex
viru
one
first
report
show
presenc
herp
simplex
viru
iga
antibodi
saliva
publish
demonstr
elev
herp
simplex
viru
iga
level
patient
peptic
ulcer
current
dogma
herp
simplex
viru
frequent
found
upper
gastrointestin
tract
ulcer
normal
gastric
duoden
mucosa
ulcer
link
infect
helicobact
pylori
iga
present
saliva
block
infect
herp
simplex
viru
demonstr
vitro
effici
viral
neutral
vivo
still
unknown
viabl
herp
simplex
viru
isol
saliva
current
method
util
viral
nucleic
acid
detect
although
quantit
measur
infecti
virion
tateishi
et
al
demonstr
nucleic
acid
detect
sensit
method
determin
herp
simplex
viru
infect
rapid
antibodi
test
develop
use
blood
sampl
modifi
exist
rapid
test
detect
antibodi
oral
fluid
would
appear
straightforward
rapid
test
would
primarili
serv
reassur
individu
absenc
herp
simplex
viru
infect
whether
rapid
test
base
detect
viral
antigen
viral
nucleic
acid
saliva
would
use
matter
debat
local
sampl
lesion
diagnosi
genit
herp
avail
situat
viral
infect
hepat
c
viru
hiv
clearli
differ
see
strong
correl
serum
salivari
antibodi
level
hepat
c
viru
infect
report
sinc
one
first
studi
success
demonstr
c
viru
antibodi
saliva
publish
sinc
rapid
test
use
saliva
evolv
rapid
test
requir
min
sampl
result
latter
test
built
platform
oraquick
advanc
rapid
test
although
hepat
c
viru
test
devic
may
becom
fda
approv
determin
presenc
antibodi
oral
sampl
futur
confirmatori
test
determin
activ
infect
still
need
hepat
c
viru
transmiss
requir
contact
propos
diagnost
might
safer
blood
test
infecti
hepat
c
viru
saliva
observ
gener
individu
periodont
diseas
gingiv
serum
viral
load
higher
virionsml
infect
salivari
contact
unlik
fulli
exclud
three
main
transmiss
rout
hiv
infect
unprotect
sexual
intercours
use
contamin
needl
transmiss
mother
child
pregnanc
birth
breastfeed
role
saliva
diagnosi
inhibit
hiv
wide
discuss
topic
review
see
et
al
shiboski
et
al
presenc
viabl
hiv
particl
saliva
controversi
detect
hiv
nucleic
acid
saliva
demonstr
clear
whether
viral
rna
detect
deriv
viabl
viral
particl
instead
repres
free
nucleic
acid
fragment
gener
viral
load
saliva
lower
correspond
blood
sampl
occasion
high
secretor
hiv
report
perhap
indic
presenc
reservoir
hiv
salivari
gland
oropharyng
tissu
infect
lymphocyt
variou
oral
sourc
possibl
sourc
hiv
viral
hypersecretor
import
recogn
presenc
reservoir
potenti
sourc
transmiss
higher
viral
rna
level
report
tonsil
biopsi
correspond
blood
sampl
even
remark
detect
hiv
copi
per
ml
parotid
cyst
aspir
individu
undetect
blood
viremia
although
presenc
reservoir
acknowledg
exist
hiv
epitheli
cell
buccal
mucosa
demonstr
saliva
regard
relev
transmiss
rout
saliva
lyse
hiv
particl
vitro
hypoton
mani
salivari
protein
demonstr
inhibit
hiv
infect
vitro
includ
lysozym
defensin
lactoferrin
secretori
leukocyt
proteas
inhibitor
salivari
agglutinin
oral
caviti
solubl
thought
inactiv
hiv
mechan
involv
bind
hiv
glycoprotein
expos
hiv
envelop
oral
caviti
major
site
infect
transmiss
virus
innat
immun
system
present
mouth
prevent
infect
eg
hiv
wherea
virus
includ
rabi
herp
simplex
viru
viru
infect
transmit
oral
particular
import
defens
antibodi
bacteri
viral
pathogen
detect
use
saliva
swab
oral
mucosa
frequenc
test
viral
bacteri
diseas
increas
commerci
entiti
becom
involv
new
product
develop
major
advantag
test
cost
patient
accept
equival
blood
test
possibl
home
test
whether
increas
test
viral
infect
recommend
depend
sever
factor
cost
extrem
import
inexpens
rapid
saliva
diagnost
use
dental
offic
provid
screen
test
mani
viral
diseas
includ
hiv
hepat
c
viru
influenza
fact
situat
antibodi
test
perform
moreov
oral
symptom
suggest
request
patient
dentist
could
conveni
initi
viral
nucleic
test
collect
appropri
oral
sampl
send
central
laboratori
analysi
inform
patient
physician
follow
altern
rapid
oral
antibodi
test
could
perform
dentist
offic
screen
result
reactiv
patient
refer
immedi
clinic
confirmatori
test
scientif
literatur
indic
sever
commerci
assay
may
suitabl
use
oral
sampl
sever
research
laboratori
develop
oral
test
infecti
diseas
sever
noninfecti
system
diseas
special
attent
requir
assay
perform
home
individu
involv
diseas
potenti
great
social
impact
eg
hiv
patient
may
alway
act
appropri
upon
receiv
test
result
larg
number
individu
visit
dentist
annual
health
profession
screen
viral
infect
dental
offic
follow
referr
physician
could
major
impact
control
transmiss
symptom
infecti
diseas
